The company's non-public offering project passed the meeting smoothly!
- Categories:News
- Author:Shengwei Xiang
- Origin:
- Time of issue:2020-06-12
- Views:0
(Summary description)On June 12, the 92nd working meeting of the 18th Issuance Review Committee of the China Securities Regulatory Commission in 2020 reviewed the company's application for non-public stock offerings. According to the review results, the company's application for non-public issuance of shares was approved.
The company's non-public offering project passed the meeting smoothly!
(Summary description)On June 12, the 92nd working meeting of the 18th Issuance Review Committee of the China Securities Regulatory Commission in 2020 reviewed the company's application for non-public stock offerings. According to the review results, the company's application for non-public issuance of shares was approved.
- Categories:News
- Author:Shengwei Xiang
- Origin:
- Time of issue:2020-06-12
- Views:0
On June 12, the 92nd working meeting of the 18th Issuance Review Committee of the China Securities Regulatory Commission in 2020 reviewed the company's application for non-public stock offerings. According to the review results, the company's application for non-public issuance of shares was approved.
Scan the QR code to read on your phone
Product
News
Research
Responsibility
Wap
Copyright © 2019 Zhejiang Starry Pharmaceutical Co., Ltd. All Rights Reserved. 浙ICP备18046522号